Bioventix (LON:BVXP) Posts Quarterly Earnings Results

Bioventix (LON:BVXP) announced its quarterly earnings data on Monday. The biotechnology company reported GBX 72.27 ($0.93) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Bioventix had a return on equity of 69.09% and a net margin of 59.51%.

Bioventix Stock Down 1.0 %

BVXP traded down GBX 25 ($0.32) during trading on Wednesday, hitting GBX 2,400 ($31.03). The company’s stock had a trading volume of 24,039 shares, compared to its average volume of 6,059. The firm has a market capitalization of £125.67 million, a P/E ratio of 15.52 and a beta of 0.35. Bioventix has a twelve month low of GBX 2,350 ($30.38) and a twelve month high of GBX 4,800 ($62.06). The stock’s fifty day moving average price is GBX 2,879.90 and its 200-day moving average price is GBX 3,347.62.

Bioventix Company Profile

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.